← Eichor
Condition: Primary Open Angle Glaucoma Or Ocular Hypertension Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Primary Open Angle Glaucoma Or Ocular Hypertension

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Phase 3 · 1 location(s) · Huons Co., Ltd. · NCT07335211
A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Press
Phase N/A · 1 location(s) · Brian Shafer · NCT07076303
Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical Prostaglan
Phase N/A · 1 location(s) · Instituto Universitario de Oftalmobiología Aplicada (Institu · NCT05039684
[KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or
Phase 3 · 1 location(s) · Kukje Pharma · NCT07662759
A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Tre
NA · 1 location(s) · Lagos State Health Service Commission · NCT07310719
DSLT for Reducing Medication in Glaucoma
Phase N/A · 1 location(s) · The Eye Institute of West Florida · NCT07390890
A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study
Phase 3 · 16 location(s) · YS Life Science Co., Ltd. · NCT07661329
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.